These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


179 related items for PubMed ID: 934791

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Update on therapy of diabetes mellitus: diet, sulfonylurea agents, and insulin.
    Davidson MB.
    Mt Sinai J Med; 1987 Mar; 54(3):199-210. PubMed ID: 3295527
    [No Abstract] [Full Text] [Related]

  • 23. Treatment with glibenclamide in maturity-onset diabetes mellitus.
    Persson I, Madsen SN.
    Geriatrics; 1971 May; 26(5):182-95. PubMed ID: 5004113
    [No Abstract] [Full Text] [Related]

  • 24. [The treatment characteristics of non-insulin-dependent diabetes mellitus].
    Balabolkin MI, Kreminskaia VM.
    Ter Arkh; 1996 May; 68(10):5-11. PubMed ID: 9026945
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Treatment of diabetes mellitus with oral antidiabetics].
    Froesch ER.
    Schweiz Med Wochenschr; 1976 Nov 27; 106(48):1665-7. PubMed ID: 827809
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Drugs for type 2 diabetes.
    Treat Guidel Med Lett; 2008 Jul 27; 6(71):47-54. PubMed ID: 18583949
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Oral hypoglycaemic agents and insulin therapy.
    Clarke BF.
    Br J Clin Pract; 1976 Jul 27; 30(6-8):136-40. PubMed ID: 952708
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Oral antidiabetics].
    Bäbler M.
    Schweiz Rundsch Med Prax; 1972 Feb 22; 61(8):242-6. PubMed ID: 4659095
    [No Abstract] [Full Text] [Related]

  • 33. Oral hypoglycaemic agents.
    Borthwick LJ, Stowers JM.
    Practitioner; 1979 Mar 22; 222(1329):358-66. PubMed ID: 450836
    [No Abstract] [Full Text] [Related]

  • 34. [Indication and method of administration of oral antidiabetic agents].
    Tasaka Y.
    Nihon Rinsho; 1997 Nov 22; 55 Suppl():99-103. PubMed ID: 9434451
    [No Abstract] [Full Text] [Related]

  • 35. [Behavior of serum insulin under the influence of glisoxepide with and without butylbiguanide].
    Birk W, Petrides P.
    Arzneimittelforschung; 1974 Mar 22; 24(0):425-9. PubMed ID: 4408033
    [No Abstract] [Full Text] [Related]

  • 36. [Late failures of oral therapy of diabetes].
    Kaeding A, Werner P.
    Dtsch Z Verdau Stoffwechselkr; 1965 Nov 22; 25(5):305-12. PubMed ID: 5888991
    [No Abstract] [Full Text] [Related]

  • 37. Clinical experience with glynclamide, a new hypoglycaemic agent.
    Burns FH.
    Med J Aust; 1969 Aug 30; 2(9):436-9. PubMed ID: 4898056
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Our experiences with Tolbutaphenone in the treatment of diabetes mellitus].
    Grujić M, Perinović M, Rizvanbegović B.
    Med Arh; 1977 Aug 30; 31(2):97-100. PubMed ID: 904375
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.